Improve survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Cells, Cultured Cell Line Neurons Tumor Cells, Cultured Lymph Nodes Macrophages T-Lymphocytes

Organisms8

Mice, Inbred C57BL Mice, Knockout Mice, Inbred BALB C Mice, Transgenic Mice, Nude Mice, SCID Animals, Newborn Rats, Sprague-Dawley

Diseases54

Neoplasm Recurrence, Local Lung Neoplasms Breast Neoplasms Adenocarcinoma Neoplasm Metastasis Disease Progression Liver Neoplasms Brain Neoplasms Lymphatic Metastasis Carcinoma, Non-Small-Cell Lung Recurrence Colorectal Neoplasms Carcinoma, Squamous Cell Neoplasms Disease Models, Animal Pancreatic Neoplasms Neoplasm Invasiveness Glioblastoma Ovarian Neoplasms Carcinoma, Hepatocellular Melanoma Carcinoma Stomach Neoplasms Postoperative Complications Multiple Myeloma Prostatic Neoplasms Bone Neoplasms Kidney Neoplasms Esophageal Neoplasms Glioma Head and Neck Neoplasms Heart Arrest Skin Neoplasms Kidney Failure, Chronic Carcinoma, Renal Cell Colonic Neoplasms Rectal Neoplasms Sarcoma Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Bile Duct Neoplasms Cholangiocarcinoma Lymphoma, Large B-Cell, Diffuse Carcinoma, Small Cell Osteosarcoma Leukemia, Lymphocytic, Chronic, B-Cell Acute Disease Hodgkin Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Sepsis Peritoneal Neoplasms Liver Failure Lymphoma Urinary Bladder Neoplasms

Chemicals and Drugs58

Antineoplastic Agents Tumor Markers, Biological Cisplatin Fluorouracil Doxorubicin Cyclophosphamide Survival of Motor Neuron 1 Protein Vincristine Proto-Oncogene Proteins RNA, Messenger Prednisone Antibodies, Monoclonal Deoxycytidine Phosphatidylinositol 3-Kinases Etoposide Immunosuppressive Agents Tumor Suppressor Protein p53 RNA, Small Interfering Antimetabolites, Antineoplastic Survival of Motor Neuron 2 Protein Neoplasm Proteins Protein-Serine-Threonine Kinases bcl-X Protein Methotrexate Dacarbazine Paclitaxel Nerve Growth Factors Antibodies, Monoclonal, Humanized Receptor, erbB-2 Vinblastine DNA-Binding Proteins Antineoplastic Agents, Alkylating Carboplatin Cytarabine Taxoids Leucovorin Enzyme Inhibitors Protein Kinase Inhibitors Transcription Factors Recombinant Proteins Caspase 3 Organoplatinum Compounds Receptor, Epidermal Growth Factor Apoptosis Regulatory Proteins bcl-Associated Death Protein Ki-67 Antigen Receptors, Estrogen NF-kappa B Bleomycin Antineoplastic Agents, Phytogenic Pyrimidines Caspases Cytokines Membrane Proteins Tumor Suppressor Proteins Camptothecin Melphalan Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Neoplasm Staging Proportional Hazards Models Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Prognosis Multivariate Analysis Immunohistochemistry Risk Factors Prospective Studies Cohort Studies Chemotherapy, Adjuvant Registries Transplantation, Homologous Predictive Value of Tests Actuarial Analysis Disease Models, Animal Drug Administration Schedule Risk Assessment Radiotherapy, Adjuvant Remission Induction Life Tables Liver Transplantation Kidney Transplantation Reverse Transcriptase Polymerase Chain Reaction SEER Program Blotting, Western Gene Expression Profiling Neoadjuvant Therapy Heart Transplantation Incidence Analysis of Variance Models, Biological Reoperation Cause of Death Hepatectomy Cardiopulmonary Resuscitation Salvage Therapy Probability Palliative Care Neoplasm Grading Radiotherapy Dosage Clinical Trials as Topic Randomized Controlled Trials as Topic Chi-Square Distribution Tissue Array Analysis Radiotherapy Transplantation, Autologous Regression Analysis Treatment Failure Tumor Burden Patient Selection Lymph Node Excision Oligonucleotide Array Sequence Analysis Severity of Illness Index Transfection Chemoradiotherapy Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Neoplasm Transplantation Clinical Trials, Phase III as Topic In Situ Nick-End Labeling Immunoenzyme Techniques Xenograft Model Antitumor Assays Cell Count Renal Dialysis Transplantation, Heterologous Dose-Response Relationship, Radiation Risk Stem Cell Transplantation Skin Transplantation Life Expectancy Infusions, Intravenous Chemoembolization, Therapeutic Gene Knockdown Techniques Statistics, Nonparametric Gastrectomy Polymerase Chain Reaction

Phenomena and Processes37

Cell Survival Graft Survival Time Factors Apoptosis Signal Transduction Cell Proliferation Gene Expression Regulation, Neoplastic Mutation Graft Rejection Microbial Viability Tissue Survival Cell Death Dose-Response Relationship, Drug Phosphorylation Cell Differentiation Cell Division Drug Resistance, Neoplasm Longevity Probability Up-Regulation Chi-Square Distribution Phenotype Gene Expression Enzyme Activation Transfection Cell Movement Gene Expression Regulation Down-Regulation RNA Interference Cell Cycle Cell Count Dose-Response Relationship, Radiation Gene Deletion Genotype Radiation Tolerance Risk Pregnancy

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Life Tables SEER Program Incidence Cause of Death Molecular Sequence Data Life Expectancy

Named Groups3

Tissue Donors Survivors Infant, Newborn

Health Care37

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Multivariate Analysis Risk Factors Prospective Studies Cohort Studies Age Factors Registries Predictive Value of Tests Actuarial Analysis Risk Assessment Life Tables SEER Program Incidence Analysis of Variance Cause of Death Probability Palliative Care Clinical Trials as Topic Randomized Controlled Trials as Topic Chi-Square Distribution Regression Analysis Treatment Failure Patient Selection Sex Factors Severity of Illness Index Clinical Trials, Phase III as Topic Dose-Response Relationship, Radiation Risk Life Expectancy Statistics, Nonparametric

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Disease-Free Survival Survival Survival Analysis Graft Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Time Factors Neoplasm Staging Proportional Hazards Models Follow-Up Studies Apoptosis Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Prognosis Neoplasm Recurrence, Local Lung Neoplasms Multivariate Analysis Breast Neoplasms Antineoplastic Agents Signal Transduction Tumor Markers, Biological Immunohistochemistry Cell Line, Tumor Adenocarcinoma Neoplasm Metastasis Risk Factors Prospective Studies Cohort Studies Chemotherapy, Adjuvant Disease Progression Mice, Inbred C57BL Cell Proliferation Liver Neoplasms Brain Neoplasms Cells, Cultured Cisplatin Lymphatic Metastasis Age Factors Registries Carcinoma, Non-Small-Cell Lung Fluorouracil Transplantation, Homologous Predictive Value of Tests Recurrence Doxorubicin Colorectal Neoplasms Cyclophosphamide Carcinoma, Squamous Cell Survival of Motor Neuron 1 Protein Gene Expression Regulation, Neoplastic Mutation Neoplasms Graft Rejection Actuarial Analysis Mice, Knockout Disease Models, Animal Drug Administration Schedule Risk Assessment Vincristine Radiotherapy, Adjuvant Pancreatic Neoplasms Neoplasm Invasiveness Remission Induction Life Tables Microbial Viability Liver Transplantation Kidney Transplantation Glioblastoma Ovarian Neoplasms Carcinoma, Hepatocellular Melanoma Reverse Transcriptase Polymerase Chain Reaction Carcinoma Tissue Survival Proto-Oncogene Proteins Mice, Inbred BALB C Cell Death SEER Program Blotting, Western Dose-Response Relationship, Drug RNA, Messenger Mice, Transgenic Stomach Neoplasms Cell Line Prednisone Phosphorylation Gene Expression Profiling Antibodies, Monoclonal Cell Differentiation Postoperative Complications Multiple Myeloma Prostatic Neoplasms Deoxycytidine Bone Neoplasms Phosphatidylinositol 3-Kinases Tissue Donors Neoadjuvant Therapy

No FAQ available that match "improve survival"